Release date: 2007-05-30
The US FDA passed the first bird flu vaccine in two days within 28 days. The US Food and Drug Administration (FDA) revealed on the morning of April 18, Beijing that the FDA passed the first bird flu vaccine for humans. The FDA said that if the avian flu epidemic, as long as the drug is injected twice in 28 days, the user will receive limited protection. In the previous test, 45% of people were immune to bird flu after the injection of this vaccine. It is understood that this drug is suitable for people aged 18-64 years old, and drug trials in other age groups are currently underway. According to the FDA, the main side effect of this drug is pain at the injection site, which can also cause headaches, muscle pain and other symptoms. It is reported that the vaccine was developed by a pharmaceutical manufacturer based in Paris, but it will not be sold commercially. The main use at present is that the government first reserves it and waits until the avian flu virus mutates and can be used when it is easily spread. ——Midi Medical Network
Plasma Products,Anti-Hbs,Safe Plasma,Safe Plasma Storage
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com